Are you Dr. Pasvolsky?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
Tel Aviv University SacklerClass of 2010
Certifications & Licensure
TX State Medical License 2023 - 2024
Publications & Presentations
PubMed
- Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.Curtis Marcoux, Sarah Pasyar, Denái R Milton, Hina N Khan, Mark R Tanner
British Journal of Haematology. 2024-11-28 - 1 citationsEfficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid Leukemia.Jason Yeh, Oren Pasvolsky, Rima M Saliba, Bradley Figgins, Christopher Wang
Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01 - Optimal infused CD34cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Babar Pal, Mark R Tanner
Blood Cancer Journal. 2024-10-31
